Zobrazeno 81 - 90
of 404
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Amer H. Zureikat, Daniel Barnett, Ying Huang, Mirna Kheir Gouda, Luke Wisniewski, Douglas B. Evans, Ben Staal, Chong-Feng Gao, Peter J. Allen, Dennis Plenker, Aatur D. Singhi, Randall E. Brand, Ying Liu, David A. Tuveson, Susan Tsai, Ian Beddows, Mohammed Aldakkak, Brian B. Haab, Johnathan Hall, Richard R. Drake
Publikováno v:
Clin Cancer Res
Purpose:A subset of pancreatic ductal adenocarcinomas (PDACs) is highly resistant to systemic chemotherapy, but no markers are available in clinical settings to identify this subset. We hypothesized that a glycan biomarker for PDACs called sialylated
Autor:
M.E. Hogg, Brian A. Boone, Kenneth K. Lee, Alessandro Paniccia, Nathan Bahary, Susannah G. Ellsworth, Amer H. Zureikat, Joal D. Beane, David L. Bartlett, Asmita Chopra, Michael T. Lotze, Aatur D. Singhi, Herbert J. Zeh, Adam C. Olson, Jacob C. Hodges, Steve Burton
Publikováno v:
Ann Surg Oncol
BACKGROUND. Neoadjuvant therapy is increasingly used for patients with pancreatic ductal adenocarcinoma (PDAC). It is unknown whether neoadjuvant chemoradiotherapy is more effective than chemotherapy (NCRT vs. NAC). We aim to compare pathological and
Autor:
Rohit Das, Savreet Sarkaria, Randall E. Brand, Alessandro Paniccia, Samer AlMasri, Kenneth E. Fasanella, Melissa E. Hogg, Anil K. Dasyam, Jennifer Chennat, Asif Khalid, Kenneth K. Lee, Adam Slivka, Herbert J. Zeh, Mazen S. Zenati, Amer H. Zureikat, David L. Bartlett, Aatur D. Singhi, Kevin McGrath
Publikováno v:
Annals of Surgery. 275:e789-e795
OBJECTIVE To evaluate the significance of UDD in IPMNs. BACKGROUND The uncinate process of the pancreas has an independent ductal drainage system. International consensus guidelines of IPMNs still consider it as a branch-duct, even though it is the m
Autor:
Steven J Hughes, Maxwell T. Trudeau, John D Christein, Mark P. Callery, Giuseppe Malleo, Charles M. Vollmer, Carlos Fernandez-Del Castillo, Claudio Bassi, Stephen W. Behrman, Laura Maggino, Thomas F. Seykora, Chad G. Ball, Christopher L Wolfgang, Adam C. Berger, Amer H Zureikat, Tara S. Kent, Horacio J. Asbun, William E. Fisher, Ronald R Salem, Michael G. House, Mark Bloomston, Euan J. Dickson, Elijah Dixon, Fabio Casciani, Mary E Dillhoff
Publikováno v:
Annals of Surgery. 276:e527-e535
To investigate the role of intraoperative estimated blood loss (EBL) on development of clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreatoduodenectomy (PD).Minimizing EBL has been shown to decrease transfusions and provide
Autor:
Brian A. Boone, Kelsey A. Musgrove, Carl Schmidt, Alan A Thomay, Pavan Rao, Britney R. Harris, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, J. Wallis Marsh
Publikováno v:
J Surg Oncol
Introduction The learning curve associated with robotic pancreatoduodenectomy (RPD) is a hurdle for new programs to achieve optimal results. Since early analysis, robotic training has recently expanded, and the RPD approach has been refined. The purp
Autor:
Ankur K. Patel, Steven A. Burton, Dwight E. Heron, Adam C. Olson, Nathan Bahary, Joshua L. Rodríguez-López, Amer H. Zureikat
Publikováno v:
Advances in Radiation Oncology
Purpose There is no consensus on treatment volumes for adjuvant stereotactic body radiation therapy (SBRT) for pancreatic cancer. Herein, we report patterns of failure after pancreatic SBRT for close/positive margins, which may inform target volume d
Autor:
Benedetto, Mungo, Abdulrahman, Hammad, Samer, AlMasri, Epameinondas, Dogeas, Ibrahim, Nassour, Aatur D, Singhi, Herbert J, Zeh, Melissa E, Hogg, Kenneth K W, Lee, Amer H, Zureikat, Alessandro, Paniccia
Publikováno v:
Surgical endoscopy.
The robotic platform is increasingly being utilized in pancreatic surgery, yet its overall merits and putative advantages remain to be adjudicated. We hypothesize that the benefits of minimally invasive pancreatic surgery are maximized in pancreatic
Autor:
Mohamed Abdelgadir Adam, Alexa Glencer, Samer AlMasri, Sharon Winters, Nathan Bahary, Aatur Singhi, Kenneth K. Lee, Alessandro Paniccia, Amer H. Zureikat
Publikováno v:
Annals of surgical oncology. 30(1)
In contrast to pancreatic ductal adenocarcinoma (PDAC), neoadjuvant therapy (NAT) for periampullary adenocarcinomas is not well studied, with data limited to single-institution retrospective reviews with small cohorts. We sought to compare outcomes o
Autor:
Maxwell T. Trudeau, Fabio Casciani, Brett L. Ecker, Laura Maggino, Thomas F. Seykora, Priya Puri, Matthew T. McMillan, Benjamin Miller, Wande B. Pratt, Horacio J. Asbun, Chad G. Ball, Claudio Bassi, Stephen W. Behrman, Adam C. Berger, Mark P. Bloomston, Mark P. Callery, Carlos Fernandez-del Castillo, John D. Christein, Mary E. Dillhoff, Euan J. Dickson, Elijah Dixon, William E. Fisher, Michael G. House, Steven J. Hughes, Tara S. Kent, Giuseppe Malleo, Ronald R. Salem, Christopher L. Wolfgang, Amer H. Zureikat, Charles M. Vollmer
This study aims to present a full spectrum of individual patient presentations of pancreatic fistula risk, and to define the utility of mitigation strategies amongst some of the most prevalent, and vulnerable scenarios surgeons encounter.The FRS has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e4438f83dfe6550d15ddf10ccc735a
https://hdl.handle.net/11562/1086003
https://hdl.handle.net/11562/1086003
Autor:
Christopher A. Chuckran, Anthony R. Cillo, Jessica Moskovitz, Abigail Overacre-Delgoffe, Ashwin S. Somasundaram, Feng Shan, Grant C. Magnon, Sheryl R. Kunning, Irina Abecassis, Amer H. Zureikat, James Luketich, Arjun Pennathur, John Sembrat, Mauricio Rojas, Daniel T. Merrick, Sarah E. Taylor, Brian Orr, Francesmary Modugno, Ron Buckanovich, Robert E. Schoen, Seungwon Kim, Umamaheswar Duvvuri, Herbert Zeh, Robert Edwards, John M. Kirkwood, Lan Coffman, Robert L. Ferris, Tullia C. Bruno, Dario A. A. Vignali
Publikováno v:
Sci Transl Med
Despite the success of immune checkpoint blockade therapy, few strategies sufficiently overcome immunosuppression within the tumor microenvironment (TME). Targeting regulatory T cells (T(regs)) is challenging, because perturbing intratumoral T(reg) f